Court grants bail to Navneet Kalra in O2 concentrator black-marketing case

During a recent raid, 524 oxygen concentrators, which are a crucial medical equipment used for Covid-19 patients, were recovered from Khan Chacha

Navneet Kalra arrest
Press Trust of India New Delhi
2 min read Last Updated : May 29 2021 | 5:00 PM IST
A Delhi court on Saturday granted bail to businessman Navneet Kalra in a case pertaining to the seizure of oxygen concentrators from his upscale restaurants, including Khan Chacha, here.

Chief Metropolitan Magistrate Arun Kumar Garg has directed the accused not to contact the customers to whom he had sold the concentrators, not to tamper with evidence or influence the witnesses, and join the investigation as and when called by the police.

During a recent raid, 524 oxygen concentrators, which are a crucial medical equipment used for Covid-19 patients, were recovered from Khan Chacha, Town Hall, and Nege & Ju restaurants owned by Kalra.

The businessman, accused of black-marketing the critical medical device, was nabbed from Gurugram on May 16 and formally arrested the next day. He had been on the run ever since the police raided his restaurants and seized the medical devices. A court had later sent him to judicial custody till June 3.

During the course of hearing on the bail plea, Additional Public Prosecutor Atul Shrivastava, representing the Delhi Police, told the court that the businessman committed a white-collar crime and made profit by selling medical devices at exorbitant price to those on death beds.

Kalra's lawyers, senior advocate Vikas Pahwa and advocate Vineet Malhotra, opposed the contentions of the police and said that their client is being made a scapegoat and had no criminal intent to cheat people as he sold the oxygen concentrators to merely help family and friends.

The police claimed that the concentrators were imported from China and were being sold at an exorbitant price of Rs 50,000 to 70,000 a piece as against its cost of Rs 16,000 to Rs 22,000.




One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusCoronavirus VaccineCoronavirus Tests

Next Story